Co-Founder / CEO
Geoffrey Mason, Esq. is the Co-Founder and CEO of FastPatentPartner, LLC, which brings you the FastPTODocs product line. Mr. Mason has over a dozen years experience managing and trying biotechnology and pharmaceutical patent cases, and managing large teams and vendors programming and developing pharmaceutical client-facing litigation databases.
Mr. Mason's experience includes representing brand and generic companies in Hatch-Waxman litigations relating to many blockbuster drugs, including Prozac®, Lovenox®, Augmentin®, Concerta®, Strattera® and Cymbalta®. Mr. Mason has significant trial experience and has first-chaired numerous discovery hearings. Mr. Mason's trial experience includes acting as lead trial counsel in a pro bono criminal matter, where he prevailed by directed verdict at the close of the government's case.
In connection with the blockbuster pharmaceutical cases Mr. Mason has litigated, Mr. Mason managed large teams and vendors programming and developing pharmaceutical client-facing litigation databases, including teams as large as several dozen attorneys resulting in the ultimate
production of millions of pages of documents. Mr. Mason has extensive personal programming experience, including both developing and implementing word processing software to migrate legacy Navy word processing databases from mainframes to PCs, and developing one of the first 3D fractal geometry landscape modeling programs ever made for a PC, if not the very first.
As a practicing attorney, Mr. Mason has continued to use his programming and database development skills to oversee teams and vendors engaged in the defensible harvesting, processing, review and production of the massive data-stores that are exchanged during litigation. He is a recognized expert in these areas as well as in e-discovery. Mr. Mason has overseen and/or directly engaged in custom application development associated with all of these processes, and is responsible for designing and overseeing the development of FastPatentPartner's proprietary PAIR harvesting system, which was used to create FastPTODocs unprecedented file history database, as well as numerous other FastPatentPartner databases and technologies.
Georgetown University Law Center J.D., cum laude, 1997
Harvard College B.A., magna cum laude, Social Studies and Biochemical Sciences, 1994
- District of Columbia
- New York
- U.S. Court of Appeals for the Federal Circuit
- U.S. Patent and Trademark Office
Eli Lilly v. Wockhardt et al.
Defended Wockhardt against two Lilly patents covering duloxetine (Cymbalta®), a $2.4 billion drug. Developed defenses that convinced Wockhardt to litigate solo against Eli Lilly after all remaining defendants ceased to actively litigate.
Johnson and Johnson v. Andrx
Asserted two patents against defendant seeking to make generic Concerta®. Convinced opposing counsel to drop sole enforceability defense immediately following successful cross-examination of key expert relating to defense; for most of the case, acted as sole attorney working with the majority of J&J's technical experts.
Aventis v. Teva et al.
Asserted patent against defendants seeking to make generic Lovenox®. Drafted motion for trial date shift that resulted in saving Aventis as much as $200 million; headed all discovery efforts at issue in said motion.
Igen (later BioVeris) v. Roche et al.
Asserted five patents against Roche relating to its use of ECL technology. Acted as most senior full time attorney; case settled successfully for $1.4 billion.
GSK v. Teva et al.
Asserted seven patents against defendants seeking to make generic Augmentin®. Acted as primary drafter of GSK's Findings of Fact and Conclusions of Law for trial.
Connaught v. GSK
Defended GSK against patent infringement claim by Connaught relating to GSK's DPT vaccine. As co-attorney, prevailed in professional mock jury trial against leading patent attorney Donald Dunner.